Molecular tracking devices quantify antigen distribution and archiving in the murine lymph node
- University of Colorado Anschutz Medical Campus, United States
Abstract
The detection of foreign antigens in vivo has relied on fluorescent conjugation or indirect read-outs such as antigen presentation. In our studies, we found that these widely used techniques had several technical limitations that have precluded a complete picture of antigen trafficking or retention across lymph node cell types. To address these limitations, we developed a 'molecular tracking device' to follow the distribution, acquisition, and retention of antigen in the lymph node. Utilizing an antigen conjugated to a nuclease-resistant DNA tag, acting as a combined antigen-adjuvant conjugate, and single-cell mRNA sequencing we quantified antigen abundance in lymph node. Variable antigen levels enabled the identification of caveolar endocytosis as a mechanism of antigen acquisition or retention in lymphatic endothelial cells. Thus, these molecular tracking devices enable new approaches to study dynamic tissue dissemination of antigen-adjuvant conjugates and identify new mechanisms of antigen acquisition and retention at cellular resolution in vivo.
Data availability
Raw and processed data for this study have been deposited at NCBI GEO under accession GSE150719. A reproducible analysis pipeline is available at https://github.com/rnabioco/antigen-tracking.
-
Molecular tracking devices quantify antigen distribution and archiving in the lymph nodeNCBI Gene Expression Omnibus, GSE150719.
-
Transcriptional basis of mouse and human dendritic cell heterogeneity revealed by single-cell profilingNCBI Gene Expression Omnibus, GSE137710.
-
ImmGen Microarray Phase 1NCBI Gene Expression Omnibus, GSE15907.
-
Single-cell RNA sequencing of lymph node stromal cells reveals niche-associated heterogeneityNCBI Gene Expression Omnibus, GSE112903.
-
Single-cell RNA-seq of the mouse lymph node lymphatic vasculature: Droplet-seqNCBI Gene Expression Omnibus, GSE145121.
-
ImmGen ULI: Systemwide RNA-seq profiles (#1)NCBI Gene Expression Omnibus, GSE109129.
Article and author information
Author details
Beth Ann Jiron Tamburini
Funding
National Institutes of Health (R01 AI121209)
- Beth Ann Jiron Tamburini
University of Colorado Department of Medicine Outstanding Early Career Scholar and RBI Clinical Scholar Award (Outstanding Early Career Scholar and RBI Clinical Scholar Award)
- Beth Ann Jiron Tamburini
American Cancer Society (Post-doctoral Fellowship)
- Shannon M Walsh
National Institutes of Health (T32 AI007405)
- Erin D Lucas
National Institutes of Health (R35 GM119550)
- Jay R Hesselberth
National Institutes of Health (T32 AI074491)
- Ryan M Sheridan
National Institutes of Health (R21 AI155929)
- Jay R Hesselberth
- Beth Ann Jiron Tamburini
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: All animal procedures were approved by the Institutional Animal Care and Use Committee at the University of Colorado under protocol number 00067.
Copyright
© 2021, Walsh et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,228
- views
-
- 311
- downloads
-
- 22
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Molecular tracking devices quantify antigen distribution and archiving in the murine lymph node
eLife 10:e62781.
https://doi.org/10.7554/eLife.62781
Further reading
-
- Cell Biology
Endometriosis is a debilitating disease affecting 190 million women worldwide and the greatest single contributor to infertility. The most broadly accepted etiology is that uterine endometrial cells retrogradely enter the peritoneum during menses, implant and form invasive lesions in a process analogous to cancer metastasis. However, over 90% of women suffer retrograde menstruation, but only 10% develop endometriosis, and debate continues as to whether the underlying defect is endometrial or peritoneal. Processes implicated in invasion include: enhanced motility; adhesion to, and formation of gap junctions with, the target tissue. Endometrial stromal (ESCs) from 22 endometriosis patients at different disease stages show much greater invasiveness across mesothelial (or endothelial) monolayers than ESCs from 22 control subjects, which is further enhanced by the presence of EECs. This is due to enhanced responsiveness of endometriosis ESCs to the mesothelium, which induces migration and gap junction coupling. ESC-PMC gap junction coupling is shown to be required for invasion, while coupling between PMCs enhances mesothelial barrier breakdown.
-
- Cell Biology
How the fate (folding versus degradation) of glycoproteins is determined in the endoplasmic reticulum (ER) is an intriguing question. Monoglucosylated glycoproteins are recognized by lectin chaperones to facilitate their folding, whereas glycoproteins exposing well-trimmed mannoses are subjected to glycoprotein ER-associated degradation (gpERAD); we have elucidated how mannoses are sequentially trimmed by EDEM family members (George et al., 2020; 2021 eLife). Although reglucosylation by UGGT was previously reported to have no effect on substrate degradation, here we directly tested this notion using cells with genetically disrupted UGGT1/2. Strikingly, the results showed that UGGT1 delayed the degradation of misfolded substrates and unstable glycoproteins including ATF6α. An experiment with a point mutant of UGGT1 indicated that the glucosylation activity of UGGT1 was required for the inhibition of early glycoprotein degradation. These and overexpression-based competition experiments suggested that the fate of glycoproteins is determined by a tug-of-war between structure formation by UGGT1 and degradation by EDEMs. We further demonstrated the physiological importance of UGGT1, since ATF6α cannot function properly without UGGT1. Thus, our work strongly suggests that UGGT1 is a central factor in ER protein quality control via the regulation of both glycoprotein folding and degradation.
